Floatz logo

Aliskiren

Glomerulonephritis, Membranous

Columbia UniversitySmall moleculePhase 4 / ApprovedDormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Glomerulonephritis, Membranous cohort.

Asset / SponsorPhaseRating
VALSARTAN
Columbia University
Phase 4BB
Rapamycin
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2NR

Same molecule, other indications

Aliskiren is also rated in:

hypertensive disorderDormant
BB
Indicative ·
68 / 100
View asset →
Abdominal ObesityDormant
B
Indicative ·
60 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →